Literature DB >> 4403853

Spironolactone--a weak enzyme inducer in man.

S A Taylor, M D Rawlins, S E Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4403853     DOI： 10.1111/j.2042-7158.1972.tb09061.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  12 in total

1.  Canrenoate disposition in dogs. Tissue distribution and elimination.

Authors:  J Kuhlmann; V Kötter; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

2.  Multiple dose kinetics of spironolactone and canrenoate-potassium in cardiac and hepatic failure.

Authors:  W Sadée; R Schröder; E von Leitner; M Dagcioglu
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

3.  The effect of spironolactone on the liver microsomal enzyme system in patients.

Authors:  E E Ohnhaus; E Gerber-Taras
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

4.  Pharmacokinetics of the new aldosterone antagonist, spirorenone, in healthy volunteers after single and repeated daily doses.

Authors:  W Krause; C Sack; W Seifert
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam.

Authors:  R Jochemsen; B R Van Beusekom; P Spoelstra; A R Janssens; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

6.  [The pharmacokinetics of digoxin during chronic spironolacton treatment (author's transl)].

Authors:  J P Masson; O Bass; H R Baur; E E Ohnhaus
Journal:  Klin Wochenschr       Date:  1978-11-01

Review 7.  Clinical pharmacokinetics of diuretics.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

8.  Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.

Authors:  C G Regårdh; L Jordö; M Ervik; P Lundborg; R Olsson; O Rönn
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

9.  Pharmacokinetics of spironolactone in man.

Authors:  U Abshagen; H Rennekamp; G Luszpinski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

10.  Metabolism of digitoxin in man and its modification by spironolactone.

Authors:  K E Wirth; J C Frölich; J W Hollifield; F C Falkner; B S Sweetman; J A Oates
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.